To listen to this archived webinar on-demand, please click here.
According to a new report by the Health Care Cost Institute, nearly three-quarters of 112 metropolitan areas across 43 states have “highly concentrated” hospital markets—showing a rise of such areas from 67% in 2012 to 72% in 2016. And in today’s regulatory environment, this trend shows no sign of deceleration as health systems grapple with reimbursement, cost and other mission critical pressures.
This M&A activity is set against a backdrop of intensive antitrust scrutiny. The Federal Trade Commission (FTC) and often state attorneys general reviews are much more challenging than they were just two years ago. Join McDermott’s healthcare antitrust team as they discuss and offer insight on what health systems and other healthcare players can do to get their next deal through. Topics include first-hand observations on various government practices, including:
For questions, please contact Julia Berman.
12:00 – 1:00pm (EST)
Webinar / McDermott Event / November 12, 2019
Getting the Deal Through: Navigating Antitrust Scrutiny of Health System Deals and BeyondBoston, MA / Speaking Engagements / October 17, 2019
Hot Trends in DOJ and SEC Enforcement & Litigation 2019 - '20Chicago, Illinois / McDermott Event / September 24, 2019
Wage the Battle to Win the War: Expert Challenges at Class CertificationWebinar / McDermott Event / September 10, 2019
The Global Antitrust M&A Landscape: What In-House Counsel Need to KnowBoston, MA / Speaking Engagements / June 25, 2019
AHLA Annual Meeting: Provider Contracts and Agreements that Burn: Antitrust Consequences of Formal WritteWebinar / Speaking Engagements / May 30, 2019
AHLA: Straight from the Source - Antitrust Implications and Lessons Learned from the Washington AG v. CHIWe use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.